Use of nMoABs for the Treatment of COVID-19 in Patients With HM.
NCT04932967
·
clinicaltrials.gov ↗
COMPLETED
Status
91
Enrollment
OTHER
Sponsor class
Conditions
Covid19
Hematological Malignancy
Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto